CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Shareholder vote results
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy CEO and President bought 1,377 shares at $7.26 ($9,997)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy SVP, General Counsel and Sec bought 16,938 shares at an average $7.83 ($132,658)
- 4 Open-market buy CEO and President bought 3,000 shares at $6.90 ($20,700)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
Page 21 of 28 · 553 filings